Literature DB >> 13721954

Immunologic production of antiangiotensin. II. Production and detection of antiangiotensin.

S D DEODHAR.   

Abstract

The parenteral administration of benzoylangiotensin II-azo-BGG to rabbits produced an antiserum with antiangiotensin activity. Antiangiotensin inhibited the biological action of p-aminobenzoylangiotensin II, valine(5)-angiotensin II (free acid form), isoleucine(5)-angiotensin II and valine(5)-angiotensin II (amide form), but it was totally inert towards angiotensin 1. Antiangiotensin activity was distinguished from that of serum angiotensinase by the following observations: (a) an angiotensinase-free gamma-globulin fraction contained antiangiotensin, (b) angiotensinase inactivated angiotensin II (both the amide and free acid forms) and angiotensin I in contrast to the remarkable specificity for angiotensin II exhibited by antiangiotensin. Serological demonstration of antiangiotensin included: (a) a comparison of its precipitin reaction with the angiotensin BGG complex with the reaction with BGG alone, (b) the partial inhibition of the precipitin reaction with the angiotensin BGG complex by angiotensin II, (c) a precipitin reaction with a different angiotensin II protein complex (cat serum). Angiotensin II administered parenterally as the free polypeptide was not antigenic.

Entities:  

Keywords:  HYPERTENSIN/antagonists

Mesh:

Substances:

Year:  1960        PMID: 13721954      PMCID: PMC2137260          DOI: 10.1084/jem.111.3.429

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  The isolation of gamma-globulins from rat, guinea pig, and rabbit plasma.

Authors:  J GOLDSTEIN; J W ANDERSON
Journal:  J Biol Chem       Date:  1957-02       Impact factor: 5.157

2.  Assay of renin and hypertension with the isolated guineapig ileum.

Authors:  Z P PICARELLI; R KUPPER; E S PRADO; J L PRADO; J R VALLE
Journal:  Circ Res       Date:  1954-07       Impact factor: 17.367

3.  Studies on antirenin.

Authors:  H LAMFROM; E HAAS; H GOLDBLATT
Journal:  Am J Physiol       Date:  1954-04

4.  Studies in synthetic immunochemistry: Preparation and antigenic properties of thyroxyl derivatives of proteins, and physiological effects of their antisera.

Authors:  R F Clutton; C R Harington; M E Yuill
Journal:  Biochem J       Date:  1938-07       Impact factor: 3.857

5.  Studies in synthetic immuno-chemistry: Observations on antisera against aspirin-protein complexes With a note on the serological reactions by A. A. Miles.

Authors:  G C Butler; C R Harington; M E Yuill
Journal:  Biochem J       Date:  1940-06       Impact factor: 3.857

6.  QUANTITATIVE STUDIES ON THE PRECIPITIN REACTION : THE ROLE OF MULTIPLE REACTIVE GROUPS IN ANTIGEN-ANTIBODY UNION AS ILLUSTRATED BY AN INSTANCE OF CROSS-PRECIPITATION.

Authors:  M Heidelberger; F E Kendall
Journal:  J Exp Med       Date:  1934-03-31       Impact factor: 14.307

7.  Immunologic production of antiangiotensin. I. Preparation of angiotensin-protein complex antigen.

Authors:  S D DEODHAR
Journal:  J Exp Med       Date:  1960-03-01       Impact factor: 14.307

8.  ON THE SEROLOGICAL SPECIFICITY OF PEPTIDES.

Authors:  K Landsteiner; J van der Scheer
Journal:  J Exp Med       Date:  1932-04-30       Impact factor: 14.307

  8 in total
  4 in total

1.  Studies on the role of angiotensin in experimental renovascular hypertension: an immunologic approach.

Authors:  A R Christlieb; T U Biber; R B Hickler
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

2.  Effect of rabbit antibodies against angiotensin-II on the pressor response to angiotensin-II and renal hypertension in the rat.

Authors:  P R Hedwall
Journal:  Br J Pharmacol       Date:  1968-11       Impact factor: 8.739

3.  PRODUCTION OF ANTIRENIN TO HOMOLOGOUS RENIN AND ITS EFFECT OF EXPERIMENTAL RENAL HYPERTENSION.

Authors:  S D DEODHAR; E HAAS; H GOLDBLATT
Journal:  J Exp Med       Date:  1964-03-01       Impact factor: 14.307

4.  Characterization of the renin-antirenin system.

Authors:  B Warren; A G Johnson; S W Hoobler
Journal:  J Exp Med       Date:  1966-06-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.